Test Price
3,700 AED✅ Home Collection Available
ONCOPRO Hereditary Cancer Risk Panel (200 Genes) – 3700 AED – DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015-accredited NGS (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily 8 AM–11 PM).
- Clinical Guidance: Post-test genetic counseling by DHA-licensed Consultant Medical Geneticist.
- Insurance: Direct billing verification & pre-approval via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The ONCOPRO panel uses advanced Next‑Generation Sequencing (NGS) to analyse 200 genes directly linked to hereditary cancer syndromes, delivering actionable insights for personalised risk management and preventive care. Full gene coverage includes coding regions and splice sites, with variant interpretation according to ACMG/AMP guidelines.
| Feature | ONCOPRO Panel (DNA Labs UAE) | Closest Alternative |
|---|---|---|
| Method | NGS with full gene coverage + splicing analysis | Targeted NGS (limited regions) |
| Genes Analysed | 200 full genes | 50–80 genes |
| Turnaround Time | 35 working days | 60+ working days |
| Clinical Interpretation | Detailed, DHA-aligned report with risk stratification | Basic variant list only |
Physician Insight & Safety Protocols
“This hereditary cancer panel is a vital proactive step. However, genetic risk must always be correlated with your personal and family history. I encourage you to review the results with your treating physician to build a tailored prevention or surveillance plan.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory: Medication & Treatment Continuity
⚠️ Important Clinical Notice
Do not discontinue any prescribed medications without consulting your treating physician. This genetic test provides risk information and does not replace ongoing medical management.
Exclusion Criteria & Patient Safety
- Mandatory Form: A completed Oncopro Hereditary Cancer Risk Clinical Information Form (Form 27) must accompany the sample; processing cannot begin without it.
- Consent: Informed consent is required per Federal Decree-Law No. 4 of 2016 on Medical Liability. Patients unable to provide consent, including minors without guardian consent, are ineligible.
- Acute Symptoms: If experiencing red-flag symptoms (unexplained weight loss, persistent pain, lump, night sweats), seek immediate medical evaluation. This test does not diagnose active cancer and should not delay urgent oncologic assessment.
- Recent Transfusion: Inform the phlebotomist if you have received a blood transfusion in the past two weeks; modified collection protocol may be required.
Patient FAQ & Clinical Guidance
1. What exactly does the ONCOPRO panel screen for?
The panel sequences 200 genes linked to hereditary breast, ovarian, colorectal, pancreatic, prostate, and other cancers. It identifies pathogenic and likely pathogenic variants that increase lifetime risk and guides personalised screening, prevention, and risk-reduction strategies.
2. How is the sample collected and transported?
A certified mobile phlebotomist collects 10 mL of whole blood in a lavender-top EDTA tube at your home and ships it immediately at 18–22°C without refrigeration. The completed Clinical Information Form (Form 27) must be provided at collection.
3. How long does it take to receive results?
Your genetic report is delivered within 35 working days from sample arrival. This timeline ensures thorough NGS analysis, bioinformatic processing, variant interpretation, and clinical validation.
4. Will insurance cover this test?
Many UAE insurers cover hereditary cancer panels with pre-approval. Contact our team via WhatsApp +971 54 548 8731 for direct billing verification and assistance.
UAE Regulatory & Data Privacy Adherence
- Data Protection: All clinical and genetic data are processed in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Health Information Security: We adhere to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields to ensure secure handling of electronic health records.
- Medical Liability & Consent: Patient consent and genetic counselling follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Accreditation: ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139). DHA Facility License No. 1143.
Clinical & Logistical Metadata
| Test Name | ONCOPRO Hereditary Cancer Risk Panel (200 Genes) |
| Price (AED) | 3,700 |
| Turnaround Time | 35 working days |
| Sample Type / Matrix | Whole Blood (Peripheral Blood, EDTA) |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full Gene Coverage |
| ICD-10-CM Code | Z15.01, Z15.02, Z15.09 |
| LOINC Code | 102876-0 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians